Rapid, low-sample-volume cholesterol and triglyceride assays

US9546394B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9546394-B2
Application numberUS-201514604538-A
CountryUS
Kind codeB2
Filing dateJan 23, 2015
Priority dateDec 10, 2012
Publication dateJan 17, 2017
Grant dateJan 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed. Assays may be performed in a single reaction mixture, allowing more accurate and precise cholesterol determinations, including ratios of cholesterol sub-fractions to total cholesterol, at less expense, than would be expected by performing several different assays in different reaction mixtures.

First claim

Opening claim text (preview).

The invention claimed is: 1. A reagent for use in an assay for the simultaneous, rapid measurement of at least two of total cholesterol, low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) in lipoproteins in a sample of blood from a subject without substantial precipitation of said lipoproteins, consisting of a sodium phosphate buffer, between about 0.01% and about 1% Triton X-100, between about 0.5 g/L and about 20 g/L pluronic L64, between about 0.5 mM and about 20 mM N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline (ALPS), horse-radish peroxidase (HRP), cholesterol esterase from Pseudomonas sp. , and cholesterol oxidase from Pseudomonas sp. 2. A kit comprising a reagent and instructions for the use of said reagent in a cholesterol assay, the reagent consisting of a sodium phosphate buffer, between about 0.01% and about 1% Triton X-100, between about 0.5 g/L and about 20 g/L pluronic L64, between about 0.5 mM and about 20 mM N-Ethyl-N-(2-hydroxy-3-sulfopropyl)- 3 , 5 -dimethoxyaniline (ALPS), horse-radish peroxidase (HRP), cholesterol esterase from Pseudomonas sp. , and cholesterol oxidase from Pseudomonas sp. 3. The kit of claim 2 , comprising a first reagent, a second reagent, and instructions for the use of said reagents in a cholesterol assay, wherein the first reagent comprises α-cyclodextrin sulfate, dextran sulfate, magnesium chloride, between about 1 mM and about 5 mM 4-aminoantipyrene and a sodium phosphate buffer, and the second reagent consists of a sodium phosphate buffer, between about 0.01% and about 1% Triton X-100, between about 0.5 g/L and about 20 g/L pluronic L64, between about 0.5 mM and about 20 mM N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline (ALPS), horse-radish peroxidase (HRP), cholesterol esterase from Pseudomonas sp. , and cholesterol oxidase from Pseudomonas sp.

Assignees

Inventors

Classifications

  • C12Q1/61Primary

    involving triglycerides · CPC title

  • acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) · CPC title

  • Chromogens for determinations of oxidoreductase enzymes · CPC title

  • Developer · CPC title

  • acting on hydrogen peroxide as acceptor (1.11) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9546394B2 cover?
Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable pro…
Who is the assignee on this patent?
Theranos Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/61. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).